Acquiring Company
Voyager Acquisition
Acquired Company
VERAXA Biotech
Brooklyn
ZurichFinancial ServicesHealth CareFinanceVenture CapitalMedicalFintechBiotechnologyHealth CareDescription
VERAXA Biotech Holding AG has successfully merged with Voyager Acquisition Corp., becoming a publicly traded entity. The merger will help advance VERAXA's innovative cancer therapies pipeline. The company will commence trading on June 11, 2026, under the ticker symbol 'VRXA'. The transaction was approved by shareholders of both companies earlier this year.
Other recent acquisitions in Financial Services and Finance
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- iCapital to acquire Citi Global Alternatives (May 13, 2025)
- GTCR to acquire Surmodics amid earnings release (April 28, 2025)
- Organon acquires Tofidence biosimilar rights (April 14, 2025)
- Globus Medical completes acquisition of Nevro Corp. (April 3, 2025)
- ARES MANAGEMENT LLC acquires Frontier Communications (March 21, 2025)
- Stifel Financial Corp. acquires Bryan Garnier & Co. (June 5, 2025)
Who to call at Voyager Acquisition, and when
When Voyager Acquisition changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Voyager Acquisition raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Voyager Acquisition, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Voyager Acquisition. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Voyager Acquisition makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired VERAXA Biotech?
VERAXA Biotech was acquired by Voyager Acquisition, based in Brooklyn. The deal was reported on April 22, 2025. Voyager is a special purpose acquisition company that focuses on revolutionizing the healthcare sector through mergers and business combinations. Voyager Acquisition is privately held and operates in Financial Services.
When did Voyager Acquisition acquire VERAXA Biotech?
Voyager Acquisition's acquisition of VERAXA Biotech was reported on April 22, 2025. VERAXA Biotech Holding AG has successfully merged with Voyager Acquisition Corp., becoming a publicly traded entity. The merger will help advance VERAXA's innovative cancer therapies pipeline. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does VERAXA Biotech do?
VERAXA Biotech is a Swiss biotechnology company focused on developing innovative oncology therapies. The company specializes in a proprietary BiTAC platform and is advancing various cancer treatment programs. It is publicly traded (VRXA), operating in Biotechnology, and is based in Zurich.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.